Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists

Details for Australian Patent Application No. 2002328931 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Rutten, Hartmut; Wehner, Volkmar; Blum, Horst; Stilz, Hans, Ulrich; Flohr, Stefanie

Agent Watermark

Pub. Number AU-B-2002328931

PCT Number PCT/EP02/08106

PCT Pub. Number WO2003/011288

Priority 101 37 595.6 01.08.01 DE

Filing date 20 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 24 April 2008

International Classifications

A61K 31/4166 (2006.01)

A61K 31/4174 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/06 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 233/70 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/72 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/74 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/86 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 101 37 595.6 01.08.01 DE

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002328931

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

24 April 2008 Application Accepted

  Published as AU-B-2002328931

21 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002328933-USE OF SORAPHEN DERIVATIVES

2002328930-COATED GRANULES OF ALLYLAMINEOR BENZYLAMINEANTI-MYCOTICS